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Abstract WW domains are small protein modules composed of
approximately 40 amino acids. These domains fold as a stable,
triple stranded L-sheet and recognize proline-containing ligands.
WW domains are found in many different signaling and
structural proteins, often localized in the cytoplasm as well as
in the cell nucleus. Based on analyses of seven structures of WW
domains, we discuss their diverse binding preferences and
sequence conservation patterns. While modeling WW domains
for which structures have not been determined we uncovered a
case of potential molecular and functional convergence between
WW and SH3 domains. The binding surface of the modeled WW
domain of Npw38 protein shows a remarkable similarity to the
SH3 domain of Sem5 protein, confirming biochemical data on
similar binding predilections of both domains. ß 2002 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
Key words: WW domain; SH3 domain;
Proline-rich binding domains; Structural comparison
1. WW domains as protein modules recognizing diverse ligands
WW domains are the smallest, naturally occurring protein
modules composed of approximately 40 amino acids. The
name refers to two signature tryptophan (W) residues that
are spaced 20^22 amino acids apart and are present in most
WW domains known to date [1]. WW domains recognize pro-
line-containing ligands and fold as a stable, triple stranded
L-sheet in absence of ligands or disul¢de bridges [2,3]. They
are found in many di¡erent proteins, often localized in the
cytoplasm as well as in the cell nucleus [4^6]. Shortly after
their characterization, WW domains attracted attention be-
cause the signaling complexes they mediate have been impli-
cated directly or indirectly in several human diseases including
Liddle’s syndrome of hypertension, muscular dystrophy, Alz-
heimer’s and Huntington’s diseases, and, more recently, can-
cer [5].
Due to its small size and compact fold, the WW domain
became an attractive model for studies of protein stability and
design [7^11]. Speci¢c residues have been identi¢ed that play a
critical role in the structure and function of the domain and
also in modulating its stability. In fact, the WW domain is the
¢rst protein module that has been successfully designed de
novo, demonstrating the signi¢cant insight we already have
regarding its fold [12]. Besides, the WW domain sequence is
well conserved in length, even in its loops, which is a remark-
able feature of this domain, compared with others, making
protein modeling a useful tool for generating three-dimension-
al representations of their sequences. Nevertheless, attempts
to predict binding targets for a speci¢c WW domain sequence
or even for one of its subgroups or classes, with a good prob-
ability, have not been made so far.
Based on the pattern of semi-conserved residues, WW do-
main sequences have been classi¢ed into three groups as de-
scribed previously [12]. Group I contains the C-terminal tryp-
tophan and the N-terminal proline, Group II sequences lack
the N-terminal proline and ¢nally Group III with sequences
without the second tryptophan. In another classi¢cation,
based on the ligand predilection, WW domains were divided
into two major and two minor groups [5]. One major group
(Group I) binds polypeptides with the minimal core consensus
PPxY, whereas the other binds ligands with the PPLP motif
usually embedded in a long stretch of prolines (Group II).
Group III WW domains select poly-P motifs £anked by R
or K, whereas Group IV WW domains bind to short sequen-
ces with phospho-S or phospho-T followed by P, in a phos-
phorylation-dependent manner [5]. A sequence alignment of
some selected WW sequences combining binding preferences
and sequence conservation is shown in Fig. 1.
In this contribution we will review the structural character-
istics of WW domain^ligand complexes determined so far. On
the basis of four WW domain structures in complex with
di¡erent peptides and two structures of free WW domains
[3,12^16], a three-dimensional structure has been modeled
for the Npw38 WW domain that allows us to compare bind-
ing properties of WW and SH3 domains.
2. WW domain as a phosphate-dependent SH3 domain?
WW domains have the ability to bind proline-rich cores
and/or phospho-SP/phospho-TP-containing motifs [5]. It is
interesting that such a small and well-conserved module has
a surprisingly large repertoire of potential ligands. The disso-
ciation constants (Kd) for WW^ligand complexes lie in the
high nM to low mM range for proline-rich ligands, and in
the low mM range for phospho-SP- or phospho-TP-contain-
ing ligands [5]. Phosphorylation of the terminal tyrosine in the
ligand PPxY for YAP65 WW domain abolishes the binding in
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vitro [2] and in vivo [17], suggesting that this modi¢cation
could represent a negative regulation mechanism for a large
subset of WW domains. Little is known about the regulation
of other WW domain complexes whose ligands do not contain
phosphorylatable residues. In its function, the WW domain
embodies elements of SH3 and SH2 domains by recognizing
proline-rich ligands and being in some cases regulated by
phosphorylation. In this sense, one could consider WW do-
mains as phosphorylation-dependent SH3 domains. As dis-
cussed later on in this review, similarities in the binding site
between WW and SH3 domains seem to be more extensive
than originally expected, at least for a subgroup of WW se-
quences.
3. What do we learn from the structures?
3.1. WW domains binding PPxY cores
Most of the structural studies performed on WW complexes
refer to WW sequences that bind to the PPxY motif, namely
YAP65 (wild-type [3] and L30K mutant [16]), dystrophin [15]
and Nedd4 [14], highlighted in blue in Fig. 1. The structures
of these complexes are compared in Fig. 2. In the central
strand and contributing to the binding site, the three WW
domain sequences have at position 28 either tyrosine or phe-
nylalanine, an aliphatic residue at position 30 (L/I/V respec-
tively) and a histidine at position 32. As it is shown in Fig. 2,
the three domains (YAP65 (L30K), dystrophin and Nedd4)
interact with the peptide in a similar manner. The tyrosine
(Y7P) of the peptide contacts residue 30 (I/K respectively)
and the histidine 32 located in the central strand as well as
the hydrophilic residue 35 (either Q/K) found at the beginning
of the third strand. The two structural prolines of the peptide
(P4P and P5P) are packed between the highly conserved aro-
matic residues Y/F28 and the W39. Compared to the YAP65
and dystrophin complexes, the Nedd4 WW domain binds a
peptide, which has a C-terminal, helical extension in addition
to the PPxY motif. The additional residues extend the contact
interface between both proteins to the ¢rst strand of the WW
domain.
When the three complexes YAP65 (L30K), Nedd4 and dys-
trophin are carefully compared, minor di¡erences can be dis-
covered. These di¡erences concern the position of the two
prolines in the peptide (P4P and P5P) that contact the aromatic
binding pocket, the orientation of the peptide tyrosine ring
(Y7P) and the distance from the peptide backbone to the
highly conserved T37. As it is shown in Figs. 1 and 2, most
of the residues localized in the last two strands and especially
those contributing to the binding site are highly conserved.
Therefore the ¢rst strand and the loop 1 that harbor the
most signi¢cant sequence divergences must be responsible
for the observed di¡erences in the peptide binding. The last
residue of the ¢rst strand, residue 22 (T/S/H respectively) is in
close contact with the second interacting proline (P5P) of the
peptide and it is not conserved. While the dystrophin WW
domain binds the second proline (P5P) of the PPxY motif
quite parallel to the Y28 ring, in the YAP65 (L30K) complex
it appears more perpendicular to it. In the Nedd4 complex
however, P5P is also parallel to the aromatic ring, but shifted
away from it. Furthermore, the preceding proline (P4P) is
buried deeper between the aromatic rings of F28 and W39
than in the other two complexes. These di¡erences in the
structures can be related to the variable surface available at
Fig. 1. Multiple sequence alignment of selected WW domain sequences generated with Clustal X [40]. The strictly conserved residues are boxed
in black and the semi-conserved residues, previously used for classifying the WW sequences [12], are boxed in yellow. Other conserved residues
are shown in gray, negatively charged residues in blue and positively charged residues in brown boxes. Residues shown in red correspond to
the suggested second binding site, as explained in the text.
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the binding site, in particular that around the aromatic ring of
Y/F28. The small serine in the dystrophin structure allows the
peptide to bulge out, while the additional methyl group of the
threonine leaves less space for P5P to pack against the Y/F28
ring and consequently leads to a rotation of the P5P in the
YAP65 structure [16]. The even bulkier histidine ring in the
Nedd4 complex ¢nally forces the peptide to move away from
the aromatic binding site. The resulting weakened interaction
between the P5P and the F28 rings could be compensated by
the extra contacts from the helical extension of the Nedd4
ligand to the ¢rst strand.
In the YAP65 (L30K) complex, the hydroxyl group of T37
Fig. 2. Structure comparison of complexes formed by WW domains binding to ligands displaying the PPxY motif. The YAP65 WW domain
(L30K) in complex with the polypeptide PPPPYTV (depicted in gray) is compared to (top panel) the dystrophin WW domain (shown in yel-
low) in complex with the SPPPYVP peptide from L-dystroglycan (in orange) and (bottom panel) to the Nedd4 WW^TPPPNYDSL complex (in
green). Hydrogen bonds are indicated by dashed lines. Colored residue labels correspond to residues that are di¡erent in the respective com-
plexes, otherwise only the residues of the YAP65 WW complex are denoted. The ¢gures have been prepared using the program MOLMOL
[41].
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in the third strand points towards the carbonyl group of P5P
(marked with a dashed line in the Fig. 2), at a distance close
enough to be involved in a hydrogen bond. In the dystrophin
and Nedd4 complexes, the hydroxyl group is in the proximity
of this carbonyl, but only a di¡erent rotamer of T37 (in which
the carbon beta and the hydroxyl will change their positions)
will allow such a hydrogen bond to occur. Mutations of this
threonine in the YAP65 WW domain only allow serine at this
position with all other amino acids leading to reduce ligand
binding a⁄nity [18]. This fact reinforces the functional role of
this residue. Remarkably, most WW sequences display an S or
T at this position (see Fig. 1), suggesting a structural relevance
for this hydrogen bond [16].
For the three above-mentioned structures and especially for
the YAP65 WW complex, where systematic substitution anal-
yses on both, peptide and protein sequences, have been per-
formed [16,18], replacement of the tyrosine residue (Y7P) of
the peptide always decreases the binding a⁄nity, even if it is
mutated to phenylalanine. The reason could be that the tyro-
sine hydroxyl group and the histidine (H32) located at the end
of the second strand of the WW domain are involved in a
hydrogen bond, as observed in the X-ray structure of the
dystrophin complex [14]. A similar decrease in a⁄nity is ob-
served when the H32 is mutated to Ala in the YAP65 WW
domain [3], supporting the idea that such a hydrogen bond is
present in all complexes between PPxY motifs and WW do-
mains. This hydrogen bond will be abolished if the tyrosine
hydroxyl group gets phosphorylated, being a way of negative
regulation of the peptide^protein interaction [2,5,17]. Finally,
mutations of the prolines in the peptide either reduce the
binding a⁄nity or abrogate the binding completely, probably
due to losses of the poly-proline type II population of the
peptide prior to binding [2,16,17].
3.2. The Pin1 and C-terminal repeat of the RNA polymerase II
complex
A surprise for the WW domain family came from the de-
scription of the prolyl-isomerase Pin1 WW (previously in-
cluded in Group I since its sequence displays the appropriate
semi-conserved residues [12]), with a phosphorylated peptide
that does not contain the PPxY motif [13]. The binding spec-
i¢city between Pin1 WW domain and its target peptide is
achieved by interactions between the phosphate group of
one phosphorylated serine in the peptide and arginine and
serine side-chains of the domain located in the ¢rst strand
and in the L1^L2 loop. Interestingly, the peptide does not
adopt the poly-proline type II conformation observed in the
other complexes, but binds to the domain in an extended
conformation and acquiring a reverse orientation with respect
to the other complexes. All WW domains present in the pro-
lyl-isomerase family ranging from yeast to humans, display a
high number of conserved positively charged residues and
serines in the binding site, all well suited to interact with
negatively charged groups such as phosphotyrosines/serines.
In addition, they exhibit an extra residue in the ¢rst loop
that folds as a type II L-turn and it allows additional contacts
from the peptide to the protein backbone. Since the residues
involved in the recognition are conserved in all Pin1 sequen-
ces, the interaction with phosphorylated peptides as well as
the peptide orientation seem to be a general feature of the
prolyl-isomerase family. In fact, this sequence is so far the
only WW domain well documented to recognize phosphory-
lated peptides [5,6]. Nedd4 WW domains were also shown to
bind to phosphorylated proteins and peptides, but more work
has to be done to document this interaction in vitro and in
vivo [5]. Some Rsp5 WW domains bind phosphorylated se-
quences [19], though with lower a⁄nity than for the un-phos-
phorylated sequence. In particular, titration experiments per-
formed on the second WW domain of Rsp5 and the sequence
used for the Pin1^peptide complex revealed a six-fold decrease
in a⁄nity when compared to the equivalent un-phosphorylat-
ed sequence (C. Civera, S. Wiesner, A. Chang, M. Sudol and
M.J. Macias, unpublished results).
3.3. Modeling of aromatic-rich WW sequences
The second group of WW sequences [12] contains the for-
min binding proteins (FBP) and other related splicing factors
such as the U1 snRNP Prp40 protein. Since the cellular role
of several of these proteins is well characterized, the targets
that interact with the WW domains are also known. All these
domains shared the presence of three or more aromatic resi-
dues in the binding site, reducing the room left for the peptide
to bind. As a consequence of this, most of these WW sequen-
ces prefer to bind highly proline-rich peptides without aro-
matic residues. For instance, the FE65 WW and FBP WW
domains 21 and 28 bind a PPLP motif [20^22]. The transcrip-
tion factor Npw38 preferentially recognizes a short proline-
rich sequence surrounded by an arginine residue, known as
the PGR motif [23,24]. Although the structure of one repre-
sentative sequence has been solved, namely that of the FBP28
WW [12], other three-dimensional structures of complexes be-
longing to this group have not been determined so far. We
have therefore tried to illustrate the interaction by modeling
one complex. However, it is evident that high-resolution struc-
tures are required to obtain a detailed description of these
interactions. We have chosen to model the Npw38 WW do-
main because it is the ¢rst WW domain shown to interact with
sequences containing charged amino acids in its peptide tar-
get. In addition, we tried to understand whether the arginine
in the peptide sequence could play a role in domain recogni-
tion. Furthermore, the target peptide for the Npw38 WW
domain also binds to SH3 domains allowing us to compare
the binding site of WW and SH3 domains [25]. The dual
ability of some peptides to interact with both domain types
has also been previously described for the formins [22], but
unfortunately three-dimensional structures of complexes
showing how two di¡erent domains could bind the same li-
gand are not available.
Considering the high number of prolines, the Npw38 WW
target peptide, RLLPPGPPP, has been modeled to adopt a
poly-proline type II helical conformation for all residues but
the arginine. For the homology modeling of the Npw38 WW
domain we used the WW structures of dystrophin, Nedd4,
Pin1 and FBP28 as structural templates and the program
MODELLER [26]. The orientation of the peptide in the
Npw38 WW complex was then modeled by superimposing
the homology model of the Npw38 WW domain to the dys-
trophin and Pin1 WW domain, respectively. The Npw38
WW:RLLPPGPPP models were then energy minimized using
the CHARMm program [27] in QUANTA (Molecular Simu-
lations Inc., 1997). Fig. 3 shows the Npw38
WW:RLLPPGPPP models with both possible peptide orien-
tations.
As can be observed in Fig. 3, both orientations of the
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Fig. 3. Models of the Npw38 WW domain in complex with the non-apeptide RLLPPGPPP. Upper panel: The ligand is oriented as in the dys-
trophin WW: L-dystroglycan complex. Lower panel: The ligand adopts the same orientation as in the Pin1 WW domain complex with a phos-
phorylated C-terminal domain repeat from the RNA polymerase II. The salt bridge between the peptide and the WW domain is indicated by
dashed lines.
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PPGPPP motif result in identical residues interacting with the
aromatic rings. This is due to the symmetry of the poly-pro-
line helix and to the presence of two proline binding pockets
on the domain surface. Considering also the N-terminal pep-
tide sequence, RLLP, the peptide orientation as observed in
the Pin1 WW complex seems more favorable. The interaction
surface is larger and a salt bridge can be formed between R1P
and D35, while L3P and P5P can contact the W30 ring. In
addition, the Gly6P kinks the poly-proline type II helix allow-
ing the two following prolines (P7P and P8P) to intercalate in
the ¢rst binding pocket formed by the Y28 and W39 rings.
The opposite orientation, however, only shows contacts from
the prolines to the aromatic rings, but no interactions from
L2P and R1P to the domain. Therefore, according to our mod-
el, the predicted interactions between the R1P and L2P may
control the binding orientation and can select a reverse ori-
entation relative to the one observed for the PPxY complexes.
Interestingly, by using peptide libraries the Npw38 WW do-
main has been shown to bind the PPLPP motif, as many
formin binding proteins do, and even PPPPPP. This suggests
that the interaction between the prolines and both binding
pockets is very stable by itself. Hence, £anking residues could
be important to de¢ne the speci¢city and thus the ¢nal peptide
orientation [28].
4. Comparison between SH3 and WW binding sites: two
di¡erent sca¡olds for binding left-handed poly-proline type II
helix ligands
The left-handed poly-proline type II helix, PPII (P=378,
B= +146), is found in proline-rich peptides although a quarter
of the PPII helices found in globular proteins do not contain
prolines [29]. Proline-rich sequences are frequently found in
inter-domain regions of multi-domain proteins and also on
the surface of many globular proteins. One reason for the
abundance of prolines in proteins is the intrinsic stability of
the PPII helix being more resistant to proteolysis. In addition,
proline residues have a £at hydrophobic surface well suited
for van der Waals interactions with aromatic residues [27,30^
32]. In particular, the stacking of prolines with aromatic rings
and the presence of a hydrogen bond between a backbone
carbonyl and the indole proton of a tryptophan seem to be
conserved for all protein domains that interact with proline-
rich peptides, such as SH3, EVH1, pro¢lin, and WW ([28] and
references therein). It is remarkable how well the two prolines
from L-dystroglycan bound to the dystrophin WW domain
and the C4^C7 residues of the abl^SH3 complex superimpose
when the tryptophans of each domain are compared [15]. In
addition, the carbonyl groups of prolines are good hydrogen
bond acceptors, increasing the binding a⁄nity by means of
backbone hydrogen bonds from the peptide to the protein
side-chains.
If the number of consecutive prolines in a peptide is equal
or longer than four, the peptide will no longer be extended in
solution, but it will adopt a PPII conformation prior to bind-
ing to the target protein [33]. As a result of this, the entropic
cost of the interaction is highly reduced by the helical con-
formation and the interaction kinetics is accelerated. One of
the most characteristic features of the poly-proline helix, how-
ever, is its symmetry. The left-handed PPII has three residues
per turn arranged in a three-fold symmetry axis. As previously
shown for a peptide with several consecutive prolines [34],
Pro(i) and P(i+4) are pointing to the same side of the helix,
in a way that their rings will occupy similar positions in space
independently from the peptide orientation. Even more intri-
guing, the peptide carbonyls of equivalent residues are able to
make hydrogen bonds to the same protein residues in both
peptide orientations. Thus the presence of the two binding
pockets in the SH3 domain allows the peptide to choose be-
tween both possible orientations, with the ¢nal orientation
being de¢ned by interactions between speci¢c residues.
A di¡erent scenario, however, is observed in WW domains
that interact with the PPxY motif. Since the binding surface
contains only a single binding pocket to allocate the proline-
rich part of the peptide, the speci¢c interactions with the ty-
rosine ring (Y7P in Fig. 2) and its hydroxyl group de¢ne the
ligand orientation. Interestingly, the WBP1 (WW domain
binding protein), that interacts with the YAP65 WW domain
[2], has several copies of the PPxY motif and one YPPPP
sequence, raising the question whether the WW domain can
also bind the reversed motif. Although the symmetry of the
PPII helix will maintain contacts between the Y7P ring and the
two prolines in both PPPPY and YPPPP, the second and
third proline of the PPPPY motif bind to the aromatic protein
binding site, while for the YPPPP motif it would be the ¢rst
and the second proline in order to maintain the tyrosine^his-
tidine hydrogen bond. Hence both peptides are not equivalent
and so far experimental data only support binding of the
PPPY motif and not of the YPPPP motif [35]. Remarkably
the YPPPPY peptide recovers the binding [36], suggesting that
it behaves as the PPxY motif itself. Therefore, it is very un-
likely that WW sequences can bind PPxY proline-rich motifs
in both orientations. Although these WW domains interact
with the proline-rich part in a similar way as SH3, pro¢lin
and EHV1 domains do, the speci¢c interactions with the re-
maining ligand residues are achieved in a very peculiar man-
ner that has only been observed for WW domains so far.
For the PPLPP binding WW sequences, the situation can be
quite di¡erent from the one described above. First their pep-
tide targets include the PxxP motif, previously described as
the SH3 binding motif. Moreover, this group of WW sequen-
ces has two potential binding pockets formed by the two sets
of aromatic clusters, also very similar to the SH3 binding site,
and a third interaction site responsible for the speci¢city (ac-
cording to our model). If the aromatic residues present in the
Sem5 SH3 and in the Npw38 WW domain are superimposed
and the peptide bound to the SH3 domain is depicted as in
Fig. 4, upper panel), both binding sites are very similar. Even
more surprising is the fact that not only the residues but also
the size of the binding site are conserved. Thus, if our model is
correct, we would conclude that nature has achieved (either by
conservation or convergence of the binding sites through evo-
lution) two sca¡olds, namely the SH3 and a subset of WW
sequences, which can accomplish a similar function. However,
three-dimensional structures of complexes between WW se-
quences and their targets as well as SH3 domains in complex
with the same peptides are required to fully prove this model
of binding site conservation. In addition, these new complexes
will help to understand in more detail the role of the variable
residues, especially those located in the connecting loops, that
regulate the speci¢city of the interactions between this set of
WW domains and proline-rich peptides [28].
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5. Do we need extra interactions from neighboring domains to
acquire speci¢city, to consolidate the WW domain structure
or both?
Some WW domains have been found embedded in larger
structures (dystrophin and Pin1 WW domains) or requiring
the presence of the ligand to increase their stability (YAP65
WW domain). In the dystrophin^L-dystroglycan complex the
EF hands and the N-terminal helix present in the protein
surround the WW domain and probably maintain it folded,
explaining why the independently expressed dystrophin WW
domain does not bind L-dystroglycan [15]. The ligand also
interacts with the ¢rst EF hand, while the WW domain binds
the PPxY motif. Since the L-dystroglycan has two PPxY mo-
tifs, the extra interactions with the EF hand can facilitate the
selection of the correct target and increase the overall binding
a⁄nity. Hence, the resulting ligand orientation is probably
originating from a dual optimization of both the structural
stability and of the binding a⁄nity. A similar situation is
observed in the Pin1 complex. There, the multiple contacts
between the prolyl-isomerase catalytic part and the WW do-
main are probably important for increasing domain stability.
This is supported by the fact that upon ligand binding, the
relative orientation of both domains changes in order to en-
large the binding area.
On the other hand, a quite di¡erent scenario is observed for
the Nedd4 complex. In this case, at least nine residues from
the peptide are involved in the binding and despite the pres-
ence of longer tails at both ends of the domain, all contacts
between the peptide and the WW domain are made through
the standard domain binding sites. Other examples for inde-
pendently folding WW domains are the FBP28 WW domain
and seven WW domains from Saccharomyces cerevisiae
(YJQ8 [12] and M.J. Macias, unpublished results), which
have been shown to be folded and stable in solution without
additional contacts to other parts of the protein or ligands, in
good agreement with their de¢nition as autonomous units
with characteristic structure and function.
As we have seen, some WW domains may require the pres-
ence of additional contacts either to improve their structural
stability or to increase their binding a⁄nity through cooper-
ativity. Such a situation, nevertheless, should be regarded as
exceptional and taken with caution. If protein domains are
supposed to be ‘the building blocks of the protein world’
[37], ‘evolutionarily mobile, and thus can occur in otherwise
non-homologous proteins but still carrying a certain con-
served function’ [38], they should be capable to function in-
dependently. The WW sca¡old is probably the shortest pro-
tein domain found in nature, but its binding site has for
example the size of an SH3 domain (Fig. 4). As suggested
for SH3 domains, we cannot exclude that both, SH3 and
WW domain, may carry ‘crude speci¢city constraints’ and
that other modular domains present in their interacting pro-
teins will tune the interactions [39]. Only more structures of
new complexes involving WW domains, together with bio-
chemical experiments will allow us to discern between what
is the rule and what are its exceptions.
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